|Videos|July 24, 2018
Non Transplant Treatments for MDS & Secondary AML
Author(s)Aplastic Anemia, MDS International Foundation
Dr. Toyosi Odenike, University of Chicago and Dr. Eric Padron, H. Lee Moffitt Cancer Center, discuss the highlights of their session on Non-Transplant Treatments for Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Advertisement
Dr. Toyosi Odenike, University of Chicago and Dr. Eric Padron, H. Lee Moffitt Cancer Center, discuss the highlights of their session on Non-Transplant Treatments for Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (AML) at the 2018 AAMDSIF International Bone Marrow Failure Disease Scientific Symposium, March 2018.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Breast Cancer Stories of 2025: Research, Treatments and Care
2
‘Full House’ Star Dave Coulier on Taking Action in the Face of Cancer
3
Why Not Me? Living Outside the CAR-T Majority
4
FDA Application Submitted for Rusfertide Treatment in Polycythemia Vera
5